Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2005
03/17/2005US20050058999 Gene involved in apoptosis regulation
03/17/2005US20050058644 Compounds for treatment of cancer using lymphocytes, monoclonal antibodies and interferons
03/17/2005US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
03/17/2005US20050058620 Modified bio-related substance, process for producing the same, and intermediate
03/17/2005DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives
03/17/2005CA2537246A1 Skin ulcer preventive or curative agent containing human recombinant hgf
03/17/2005CA2536934A1 Method for differentiating mesenchymal stem cell into hepatocyte and artificial human hepatocyte
03/16/2005EP1514942A1 Method of searching substane having antidiabetic activity
03/16/2005EP1514930A1 Novel screening method
03/16/2005EP1514870A1 Prodrug and process for producing the same
03/16/2005EP1514869A1 Indole, indazole, and benzazole derivative
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor
03/16/2005EP1514557A1 Preventives/remedies for bone and joint diseases
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1514551A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
03/16/2005EP1514547A1 Controlled-release drug composition
03/16/2005EP1514542A1 Medicinal compositions improving brain function and method for improving brain function
03/16/2005EP1514540A1 Calcium-containing tissue strengthening agents and use thereof
03/16/2005EP1514116A1 Oxaliplatin anti-resistance agent
03/16/2005EP1513959A2 Antiviral inhibitions of capsid proteins
03/16/2005EP1513941A2 Preparation of microbial oil containing polyunsaturated fatty acids
03/16/2005EP1513922A1 Pasteurisation process for microbial cells and microbial oil
03/16/2005EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/16/2005EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
03/16/2005EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
03/16/2005EP1513858A2 Process for the preparation of heterocyclyl substituted adenosine derivatives
03/16/2005EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists
03/16/2005EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/16/2005EP1513840A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
03/16/2005EP1513839A1 3-substituted quinuclidines and their use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
03/16/2005EP1513833A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
03/16/2005EP1513831A1 Novel compounds, their use and preparation
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513826A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
03/16/2005EP1513821A1 Protein kinase inhibitors
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513818A2 Heterocyclic inhibitors of kinases
03/16/2005EP1513812A1 Substituted indoles
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
03/16/2005EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors
03/16/2005EP1513806A1 New salts
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513795A2 Propionic acid derivatives and their use as hppars activators
03/16/2005EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/16/2005EP1513538A2 Novel methods for the delivery of polynucleotides to cells
03/16/2005EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
03/16/2005EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
03/16/2005EP1513527A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
03/16/2005EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513524A2 Ether substituted imidazopyridines
03/16/2005EP1513523A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
03/16/2005EP1513521A2 Pyranoindazoles and their use for the treatment of glaucoma
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES
03/16/2005EP1513511A1 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
03/16/2005EP1513501A2 Simple and multiple emulsions for decontamination of an organism or surfaces
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1513493A2 Analgesics
03/16/2005EP1513482A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
03/16/2005EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
03/16/2005EP1435899A4 A composition for promoting hair growth
03/16/2005EP1425283B1 Novel 4-aminofuropyrimidines and the use thereof
03/16/2005EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors
03/16/2005EP1353693B1 Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer
03/16/2005EP1351962B1 Thienopyrimidine
03/16/2005EP1250358B1 Therapeutic peptides
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP1189640B1 Complex of eletriptan and sulphobutylether-cyclodextrin and its use for the treatment of migraine
03/16/2005EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
03/16/2005EP1146873B1 Anti-androgens and methods for treating disease
03/16/2005EP1140900B1 Pyrazole compounds and uses thereof
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP1032401B1 Method for inhibiting cytokine production by cells
03/16/2005EP0929553B1 Pyrimidine derivatives and processes for the preparation thereof
03/16/2005EP0907737B1 Il-6 mutein
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005EP0861329B1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
03/16/2005EP0808164B1 Use of prolactin modulators and diet for the manufacture of a medicament for the treatment of obesity
03/16/2005CN1596371A Novel self-assembly molecules
03/16/2005CN1596314A Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
03/16/2005CN1596303A Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596263A Aryl fused azapolycyclic compounds
03/16/2005CN1596258A Adenosine A2a receptor antagonists
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
1 ... 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 ... 1564